Response to 'Inaccurate conclusions by Tang and colleagues'
ISTH Academy. Tang N. 04/20/20; 293253
Mr. Ning Tang
Contributions
Contributions
Journal Abstract
Abstract
We appreciate the opportunity to respond to the letter from Dr. Greenstein. It’s true that most of the heparin users just received a prophylaxis dose in our study, due to lack of evidence of arterial or venous thromboembolism (VTE), and typical signs of disseminated intravascular coagulation (DIC) in majority of the patients, some of them were also too unstable to transport for imaging examinations. Therapeutic dose of heparin has been used in patients with definite thrombosis and not been specifically mentioned in our paper.
{{ help_message }}
{{filter}}